France Mesenchymal Stem Cells Market Size & Outlook
France mesenchymal stem cells market, 2018-2030 (US$M)
Related Markets
France mesenchymal stem cells market highlights
- The France mesenchymal stem cells market generated a revenue of USD 141.5 million in 2023 and is expected to reach USD 338.6 million by 2030.
- The France market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & services in 2023.
- Services is the most lucrative product & services segment registering the fastest growth during the forecast period.
Mesenchymal stem cells market data book summary
| Market revenue in 2023 | USD 141.5 million |
| Market revenue in 2030 | USD 338.6 million |
| Growth rate | 13.3% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, Merck KGaA, Lonza Group Ltd, PromoCell GmbH, Cyagen Biosciences, Stemedica Cell Technologies, Axol Bioscience, Celprogen, Cellcolabs, Visual Photonics Epitaxy |
Other key industry trends
- In terms of revenue, France accounted for 4.5% of the global mesenchymal stem cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany mesenchymal stem cells market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 325.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mesenchymal Stem Cells Market Scope
Mesenchymal Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France mesenchymal stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mesenchymal stem cells market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 79.72% in 2023. Horizon Databook has segmented the France mesenchymal stem cells market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
France is focusing on increasing number of stem cell clinical trials. Researchers are studying intravenous injection of autologous MSCs therapy for treating ischemic stroke. Such active engagement is anticipated to drive the MSCs market in the country.
The MSC are produced by ECELLFrance’s production platforms. Such research infrastructure is anticipated to provide support to research community, aiding the MSC market growth. Furthermore, collaborations between local companies and research institutes can boost the market growth in France.
The funds will be used to expand and optimize the development of MSC-based therapies for various applications. The joint funding program by Occitanie Region and the State is anticipated to strengthen the stem cells market for Innovative Therapy Drugs (ITDs). This is expected to impact the MSCs market and their therapeutic applications significantly.
Reasons to subscribe to France mesenchymal stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France mesenchymal stem cells market databook
-
Our clientele includes a mix of mesenchymal stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France mesenchymal stem cells market , including forecasts for subscribers. This country databook contains high-level insights into France mesenchymal stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France mesenchymal stem cells market size, by product & services, 2018-2030 (US$M)
France Mesenchymal Stem Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
